111 Inc. Co-Founders Launch $4.52 Per ADS Buyout Bid

The board of Shanghai-based healthcare platform 111 Inc. is reviewing an unsolicited, non-binding proposal from its own leadership to take the company private. Co-founders Dr. Gang Yu and Junling Liu, alongside Huadeng Tech BioArray Ventures Ltd, have offered to acquire all outstanding shares not already under their control.

Today, 11:27· Money Talk· 1,260 reads

111 Inc. Co-Founders Launch $4.52 Per ADS Buyout Bid

The proposed deal values the company at US$0.226 per Class A ordinary share, or US$4.52 per American depositary share. The buyer group intends to finance the transaction through a combination of rollover equity and cash contributions from the sponsor and its affiliates.

Directors at the NASDAQ-listed firm emphasized that the offer remains in its preliminary stages. The board has not yet evaluated the terms, and there is no guarantee that a definitive agreement will be reached or that the transaction will proceed. The company plans to file the formal proposal letter with the U.S. Securities and Exchange Commission via a Form 6-K, providing investors with the full details of the offer.

111 Inc. Co-Founders Launch $4.52 Per ADS Buyout Bid

Comments (0)